BiotechTubeBiotechTube
Home/Praxis Precision Medicines/Jill Desimone
JD

Jill Desimone

Director

Praxis Precision Medicines

Therapeutic Areas

NeurologyEpilepsyCentral Nervous SystemRare DiseasesPediatric Medicine

Praxis Precision Medicines Pipeline

DrugIndicationPhase
RESILIENCE ProgramDevelopmental and Epileptic Encephalopathy (DEE)Phase 2/3
ENERGY ProgramEssential Tremor & Focal Onset SeizuresPhase 2/3
EMBOLD StudySCN2A/SCN8A DEE in childrenPhase 2/3
EMBRAVE StudyEarly-onset SCN2A DEE in childrenPhase 2/3
EMERALD StudyDevelopmental and Epileptic Encephalopathies (DEE)Phase 2/3
Essential3 StudyEssential TremorPhase 2/3
POWER1 StudyFocal Onset Seizures in adultsPhase 2/3

Leadership Team at Praxis Precision Medicines

MS
Marcio Souza
President & Chief Executive Officer
SP
Steve Petrou
Co-Founder, President of Research & Development
TK
Tim Kelly
Chief Financial Officer
AW
Alyssa Wyant
Chief Regulatory & Quality Officer
MS
Megan Sniecinski
Chief Operating Officer
KM
Kelly McCue
Chief People Officer
KH
Karl Hansen
Chief Technical Operations Officer
AN
Alex Nemiroff
General Counsel
BS
Brian Spar
Chief of Staff
DM
Dean Mitchell
Chairman of the Board
View full Praxis Precision Medicines profile